A combined defect in the biosynthesis of N- and O-glycans in patients with cutis laxa and neurological involvement: The biochemical characteristics

Suzan Wopereis, Eva Morava-Kozicz, Stephanie Grünewald, Philippa B. Mills, Bryan G. Winchester, Peter Clayton, Paul Coucke, Karin M.L.C. Huijben, Ron A. Wevers

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Based on our preliminary observation of abnormal glycosylation in a cutis laxa patient, nine cutis laxa patients were analyzed for congenital defects of glycosylation (CDG). Isoelectric focusing of plasma transferrin and apolipoproteinC-III showed that three out of nine patients had a defect in the biosynthesis of N-glycans and core 1 mucin type O-glycans, respectively. Mass spectrometric N-glycan analyses revealed a relative increase of glycans lacking sialic acid and glycans lacking sialic acid and galactose residues. Mutation analysis of the fibulin-5 gene (FBLN5), which has been reported in cases of autosomal recessive cutis laxa, revealed no mutations in the patients' DNA. Evidence is presented that extracellular matrix (ECM) proteins of skin are likely to be highly glycosylated with N- and/or mucin type O-glycans by using algorithms for predicting glycosylation. The conclusions in this study were that the clinical phenotype of autosomal recessive cutis laxa seen in three patients is not caused by mutations in the FBLN5 gene. Our findings define a novel form of CDG with cutis laxa and neurological involvement due to a defect in the sialylation and/or galactosylation of N- and O-glycans. Improper glycosylation of ECM proteins of skin may form the pathophysiological basis for the cutis laxa phenotype.

Original languageEnglish (US)
Pages (from-to)156-164
Number of pages9
JournalBiochimica et Biophysica Acta - Molecular Basis of Disease
Volume1741
Issue number1-2
DOIs
StatePublished - Jun 30 2005
Externally publishedYes

Fingerprint

Cutis Laxa
Polysaccharides
Glycosylation
Extracellular Matrix Proteins
N-Acetylneuraminic Acid
Mutation
Genes
Phenotype
Mucin-1
Skin
Isoelectric Focusing
Mucins
Transferrin
Galactose
Observation
DNA

Keywords

  • Congenital disorder of glycosylation
  • Cutis laxa
  • Glycan biosynthesis defect
  • N-glycosylation
  • O-glycosylation

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology

Cite this

A combined defect in the biosynthesis of N- and O-glycans in patients with cutis laxa and neurological involvement : The biochemical characteristics. / Wopereis, Suzan; Morava-Kozicz, Eva; Grünewald, Stephanie; Mills, Philippa B.; Winchester, Bryan G.; Clayton, Peter; Coucke, Paul; Huijben, Karin M.L.C.; Wevers, Ron A.

In: Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1741, No. 1-2, 30.06.2005, p. 156-164.

Research output: Contribution to journalArticle

Wopereis, Suzan ; Morava-Kozicz, Eva ; Grünewald, Stephanie ; Mills, Philippa B. ; Winchester, Bryan G. ; Clayton, Peter ; Coucke, Paul ; Huijben, Karin M.L.C. ; Wevers, Ron A. / A combined defect in the biosynthesis of N- and O-glycans in patients with cutis laxa and neurological involvement : The biochemical characteristics. In: Biochimica et Biophysica Acta - Molecular Basis of Disease. 2005 ; Vol. 1741, No. 1-2. pp. 156-164.
@article{76ded03470eb4c6895aec75280ab35a1,
title = "A combined defect in the biosynthesis of N- and O-glycans in patients with cutis laxa and neurological involvement: The biochemical characteristics",
abstract = "Based on our preliminary observation of abnormal glycosylation in a cutis laxa patient, nine cutis laxa patients were analyzed for congenital defects of glycosylation (CDG). Isoelectric focusing of plasma transferrin and apolipoproteinC-III showed that three out of nine patients had a defect in the biosynthesis of N-glycans and core 1 mucin type O-glycans, respectively. Mass spectrometric N-glycan analyses revealed a relative increase of glycans lacking sialic acid and glycans lacking sialic acid and galactose residues. Mutation analysis of the fibulin-5 gene (FBLN5), which has been reported in cases of autosomal recessive cutis laxa, revealed no mutations in the patients' DNA. Evidence is presented that extracellular matrix (ECM) proteins of skin are likely to be highly glycosylated with N- and/or mucin type O-glycans by using algorithms for predicting glycosylation. The conclusions in this study were that the clinical phenotype of autosomal recessive cutis laxa seen in three patients is not caused by mutations in the FBLN5 gene. Our findings define a novel form of CDG with cutis laxa and neurological involvement due to a defect in the sialylation and/or galactosylation of N- and O-glycans. Improper glycosylation of ECM proteins of skin may form the pathophysiological basis for the cutis laxa phenotype.",
keywords = "Congenital disorder of glycosylation, Cutis laxa, Glycan biosynthesis defect, N-glycosylation, O-glycosylation",
author = "Suzan Wopereis and Eva Morava-Kozicz and Stephanie Gr{\"u}newald and Mills, {Philippa B.} and Winchester, {Bryan G.} and Peter Clayton and Paul Coucke and Huijben, {Karin M.L.C.} and Wevers, {Ron A.}",
year = "2005",
month = "6",
day = "30",
doi = "10.1016/j.bbadis.2004.11.009",
language = "English (US)",
volume = "1741",
pages = "156--164",
journal = "Biochimica et Biophysica Acta - Molecular Basis of Disease",
issn = "0925-4439",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - A combined defect in the biosynthesis of N- and O-glycans in patients with cutis laxa and neurological involvement

T2 - The biochemical characteristics

AU - Wopereis, Suzan

AU - Morava-Kozicz, Eva

AU - Grünewald, Stephanie

AU - Mills, Philippa B.

AU - Winchester, Bryan G.

AU - Clayton, Peter

AU - Coucke, Paul

AU - Huijben, Karin M.L.C.

AU - Wevers, Ron A.

PY - 2005/6/30

Y1 - 2005/6/30

N2 - Based on our preliminary observation of abnormal glycosylation in a cutis laxa patient, nine cutis laxa patients were analyzed for congenital defects of glycosylation (CDG). Isoelectric focusing of plasma transferrin and apolipoproteinC-III showed that three out of nine patients had a defect in the biosynthesis of N-glycans and core 1 mucin type O-glycans, respectively. Mass spectrometric N-glycan analyses revealed a relative increase of glycans lacking sialic acid and glycans lacking sialic acid and galactose residues. Mutation analysis of the fibulin-5 gene (FBLN5), which has been reported in cases of autosomal recessive cutis laxa, revealed no mutations in the patients' DNA. Evidence is presented that extracellular matrix (ECM) proteins of skin are likely to be highly glycosylated with N- and/or mucin type O-glycans by using algorithms for predicting glycosylation. The conclusions in this study were that the clinical phenotype of autosomal recessive cutis laxa seen in three patients is not caused by mutations in the FBLN5 gene. Our findings define a novel form of CDG with cutis laxa and neurological involvement due to a defect in the sialylation and/or galactosylation of N- and O-glycans. Improper glycosylation of ECM proteins of skin may form the pathophysiological basis for the cutis laxa phenotype.

AB - Based on our preliminary observation of abnormal glycosylation in a cutis laxa patient, nine cutis laxa patients were analyzed for congenital defects of glycosylation (CDG). Isoelectric focusing of plasma transferrin and apolipoproteinC-III showed that three out of nine patients had a defect in the biosynthesis of N-glycans and core 1 mucin type O-glycans, respectively. Mass spectrometric N-glycan analyses revealed a relative increase of glycans lacking sialic acid and glycans lacking sialic acid and galactose residues. Mutation analysis of the fibulin-5 gene (FBLN5), which has been reported in cases of autosomal recessive cutis laxa, revealed no mutations in the patients' DNA. Evidence is presented that extracellular matrix (ECM) proteins of skin are likely to be highly glycosylated with N- and/or mucin type O-glycans by using algorithms for predicting glycosylation. The conclusions in this study were that the clinical phenotype of autosomal recessive cutis laxa seen in three patients is not caused by mutations in the FBLN5 gene. Our findings define a novel form of CDG with cutis laxa and neurological involvement due to a defect in the sialylation and/or galactosylation of N- and O-glycans. Improper glycosylation of ECM proteins of skin may form the pathophysiological basis for the cutis laxa phenotype.

KW - Congenital disorder of glycosylation

KW - Cutis laxa

KW - Glycan biosynthesis defect

KW - N-glycosylation

KW - O-glycosylation

UR - http://www.scopus.com/inward/record.url?scp=20444442445&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20444442445&partnerID=8YFLogxK

U2 - 10.1016/j.bbadis.2004.11.009

DO - 10.1016/j.bbadis.2004.11.009

M3 - Article

C2 - 15955459

AN - SCOPUS:20444442445

VL - 1741

SP - 156

EP - 164

JO - Biochimica et Biophysica Acta - Molecular Basis of Disease

JF - Biochimica et Biophysica Acta - Molecular Basis of Disease

SN - 0925-4439

IS - 1-2

ER -